Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.500 +0.290 (+9.03%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

February 28, 2025

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

February 24, 2025

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates

November 12, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine to Participate in Upcoming Investor Conferences

November 06, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

12 High-Growth Stocks That Could Deliver Parabolic Returns ↗

October 28, 2024

These 12 innovative companies could deliver exponential returns over the next quarter century.

Via The Motley Fool

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson’s Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

October 24, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Why I Keep Buying These 14 Incredible Growth Stocks ↗

October 16, 2024

This diverse set of growth stocks offers tremendous opportunities in the fields of AI, space, biotech, and emerging industries.

Via The Motley Fool

Topics Artificial Intelligence

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson’s Disease, at Upcoming Scientific Meetings

October 15, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Why Prime Medicine Stock Soared Nearly 12% Higher on Monday ↗

September 30, 2024

Changes are afoot at the company, and investors welcomed them.

Via The Motley Fool

Dow Dips 300 Points; Emcore Shares Spike Higher ↗

September 30, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 30, 2024

Via Benzinga

Crude Oil Moves Higher; Prime Medicine Shares Spike Higher ↗

September 30, 2024

Via Benzinga

Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday ↗

September 30, 2024

Via Benzinga

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline ↗

September 30, 2024

Prime Medicine enters a strategic collaboration with Bristol Myers Squibb to develop next-gen T-cell therapies, securing $110 million upfront with potential for $3.5 billion in milestones. The company...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

Prime Medicine Unveils Strategically Focused Pipeline

September 30, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies

September 30, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

2 Growth Stocks That Could Make You Richer ↗

August 28, 2024

Discover two cutting-edge growth stocks that could revolutionize medicine and space exploration.

Via The Motley Fool

Prime Medicine to Participate in Upcoming Investor Conferences

August 28, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024 ↗

August 08, 2024

PRME stock results show that Prime Medicine missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates

August 08, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine to Present at Upcoming Investor Conferences

May 30, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗

May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

Via InvestorPlace

Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio ↗

May 25, 2024

Alphabet may have strong insight into both company's industries.

Via The Motley Fool

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 ↗

May 17, 2024

Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential.

Via InvestorPlace

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗

May 17, 2024

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Via InvestorPlace

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024 ↗

May 10, 2024

PRME stock results show that Prime Medicine beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

May 10, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.